APLICOR 3D Trademark

Trademark Overview


On Monday, April 15, 2024, a trademark application was filed for APLICOR 3D with the United States Patent and Trademark Office. The USPTO has given the APLICOR 3D trademark a serial number of 98500440. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 8, 2025. This trademark is owned by Harbinger Medical Group, LLC. The APLICOR 3D trademark is filed in the Pharmaceutical Products, Machinery Products, and Medical Instrument Products categories with the following description:

3D bioprinters

human allograft tissue; biological tissue grafts

Medical kits for the collection and processing of adipose tissue for skin regeneration via 3D bioprinting, comprised of adipose micronizers, which mechanically fragment harvested adipose tissue into micro-sized particles suitable for bioprinting applications, 3D Regen polycaprolactone (PCL), 3D-printed scaffolds, 3D Regen polycaprolactone (PCL); a PCL holder designed to facilitate the secure and efficient loading of PCL filament into a 3D printer, adhesive film used as a print bed surface to enhance bonding and structural stability of the extruded PCL scaffold during fabrication, and blank near field communication (NFC) tags used to enable secure transmission of printing data and to prevent improper medical use of the printed constructs.

General Information


Serial Number98500440
Word MarkAPLICOR 3D
Filing DateMonday, April 15, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services3D bioprinters
Goods and Serviceshuman allograft tissue; biological tissue grafts
Pseudo MarkAPLICOR THREE D
NOT AVAILABLE3D
Goods and ServicesMedical kits for the collection and processing of adipose tissue for skin regeneration via 3D bioprinting, comprised of adipose micronizers, which mechanically fragment harvested adipose tissue into micro-sized particles suitable for bioprinting applications, 3D Regen polycaprolactone (PCL), 3D-printed scaffolds, 3D Regen polycaprolactone (PCL); a PCL holder designed to facilitate the secure and efficient loading of PCL filament into a 3D printer, adhesive film used as a print bed surface to enhance bonding and structural stability of the extruded PCL scaffold during fabrication, and blank near field communication (NFC) tags used to enable secure transmission of printing data and to prevent improper medical use of the printed constructs.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs.
US Class Codes013, 019, 021, 023, 024, 031, 034, 035
Class Status Code6 - Active
Class Status DateMonday, April 15, 2024
Primary Code007
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 8, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameROKIT HEALTHCARE INC.
Party Type12 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSEOUL 08512
KR

Party NameTIDES MEDICAL, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressLAFAYETTE, LA 70508

Party NameHarbinger Medical Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLafayette, LA 70508

Trademark Events


Event DateEvent Description
Monday, April 15, 2024NEW APPLICATION ENTERED
Monday, July 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 28, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, July 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 29, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 29, 2024ASSIGNED TO EXAMINER
Thursday, November 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 14, 2024NON-FINAL ACTION E-MAILED
Thursday, November 14, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 18, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 19, 2025TEAS PETITION TO REVIVE RECEIVED
Wednesday, February 19, 2025PETITION TO REVIVE-GRANTED
Wednesday, February 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 8, 2025ASSIGNED TO PETITION STAFF
Tuesday, April 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 8, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 8, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 8, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 8, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 8, 2025TEAS/EMAIL CORRESPONDENCE ENTERED